Triple-negative breast cancer (TNBC) is a subtype of breast cancer in which both estrogen receptor (ER) and progesterone receptor (PR) expression are <1% and human epidermal growth factor receptor 2 (HER2) is negative, accounting for 15%-20% of all breast cancers. Here, ESR1 is linked to breast cancer.